Detecting Seizures While They Happen
Mentis Care is building the world’s leading seizure detection and prediction AI platform, bringing continuous neurological monitoring from the clinic into daily life.
About Us
A Global Joint Effort for Digital Health
Mentis Care is a joint venture between SK Biopharmaceuticals and Eurofarma, formed to expand neurological care beyond pharmaceuticals through emerging digital technologies.
The company builds on the partners’ understanding of clinical practice, patient experience, and healthcare ecosystem, with a shared commitment to advancing neurological understanding through responsible, evidence-driven innovation.
Epilepsy Care Today
A Continuous Condition, Monitored Episodically
Epilepsy is a chronic, highly variable neurological condition that unfolds continuously across days, nights, and real-world contexts.
Yet care decisions are often informed by short EEG recordings and retrospective reporting, capturing only fragments of a condition that evolves over time.
This structural mismatch limits the ability to:
Seizure Burden
Response
Patterns in Symptoms
Our Approach
From Episodic Measurement to Continuous Understanding
Mentis Care is developing a platform that combines wearable EEG with AI, designed to provide a more comprehensive picture of epilepsy patients
Designed for discreet, long-term use, the wearable EEG will monitor patients 24/7 outside the clinic.
Trained with extensive clinical data, our AI model will automatically record detected seizures and alert patients when a seizure is predicted.
By enabling extended monitoring outside the clinic and interpreting signals in a long-term context, we will help align how epilepsy is measured with how it is experienced in daily life.
This provides value across the epilepsy ecosystem:
Longitudinal insight for informed assessment & care decisions.
Empowerment through greater visibility into their condition
Peace-of-mind from continuous monitoring and real-time alert
